"We are attentive, diligently committed to every detail as we deliver consistently high quality data to our sponsors. We are inventive, embracing a visionary, entrepreneurial spirit that compels us to blaze new trails with proprietary systems and processes. We are Aventiv Research. Aventiv Research is a clinical trial and medical research center. We provide clinical trial opportunities in Columbus for individuals suffering from various chronic diseases, as well as paid clinical trial options for healthy volunteers. We are located near the Columbus Airport. Contact us today or visit our website for additional information about enrolling in a clinical trial!"

During the past decade, Aventiv Research Inc. conducted 112 clinical trials. In the 10-year time frame, 112 clinical trials started and 68 clinical trials were completed, i.e. on average, 60.7% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 54 clinical trials were completed. i.e. 94.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aventiv Research Inc." #1 sponsor was "Eli Lilly and Company" with 22 trials, followed by "Pfizer" with 18 trials sponsored, "Allergan" with 8 trials sponsored, "BioNTech SE" with 6 trials sponsored and "GTx" with 6 trials sponsored. Other sponsors include 69 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aventiv Research Inc." #1 collaborator was "Pfizer" with 6 trials as a collaborator, "Iqvia Pty Ltd" with 2 trials as a collaborator, "Medpace, Inc." with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator and "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Aventiv Research Inc." are "COVID-19" (7 trials), "Osteoarthritis" (7 trials), "Type 2 Diabetes Mellitus" (7 trials), "Chronic Pain" (6 trials) and "SARS-CoV-2 Infection" (6 trials). Many other conditions were trialed in "Aventiv Research Inc." in a lesser frequency.

Most popular intervention types in "Aventiv Research Inc." are "Drug" (96 trials), "Biological" (33 trials), "Other" (20 trials), "Device" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (65 trials), "Tirzepatide" (8 trials), "BNT162b2" (5 trials), "placebo" (4 trials) and "Dulaglutide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Aventiv Research Inc." are 119 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Aventiv Research Inc.". undefined are not yet recruiting, 11 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 89 completed trials in Aventiv Research Inc., undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Aventiv Research Inc., 6 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".